Anna Maria Calcagno

A "Silent" Polymorphism in the <i>MDR</i> 1 Gene Changes Substrate Specificity

Chava Kimchi‐Sarfaty, Jung Mi Oh, In‐Wha Kim et al. · Science · 2006 · 2.5K citations · Full text

Medicine, Genetics, Molecular Genetics +15

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics

Mollie H. Wright, Anna Maria Calcagno, Crystal D. Salcido et al. · Breast Cancer Research · 2008 · 660 citations · Full text

Medicine, Cell Biology, Oncology +17

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma et al. · Proceedings of the National Academy of Sciences · 2011 · 474 citations · Full text

Medicine, Cancer Biology, Oncology +16

Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics

Anna Maria Calcagno, Crystal D. Salcido, Jean-Pierre Gillet et al. · JNCI Journal of the National Cancer Institute · 2010 · 285 citations · Full text

Medicine, Cell Biology, Oncology +17

Modulatory effects of plant phenols on human multidrug‐resistance proteins 1, 4 and 5 (ABCC1, 4 and 5)

Chung‐Pu Wu, Anna Maria Calcagno, Stephen B. Hladky et al. · FEBS Journal · 2005 · 160 citations · Full text

Life Sciences, Botany, Pharmacology +12